| Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors A Ruiz, S Benucci, U Duthaler, C Bachmann, M Franchini, F Noreen, ... Elife 11, e73718, 2022 | 8 | 2022 |
| O. 04 Improvement of muscle strength in a mouse model for recessive RYR1-related congenital myopathy treated with HDAC and inhibitors A Ruiz, S Benucci, M Franchini, S Treves, F Zorzato Neuromuscular Disorders 32, S43, 2022 | | 2022 |
| Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies C Bachmann, M Franchini, LR Van den Bersselaar, N Kruijt, ... Brain communications 4 (5), fcac224, 2022 | | 2022 |
| BRAIN COMMUNICATIONS C Bachmann, M Franchini, LR Van den Bersselaar, N Kruijt, ... | | 2022 |
| ACCECPTED MANUSCRIPT C Bachmann, M Franchini, LR Van den Bersselaar, N Kruijt, ... | | 2022 |
| CONGENITAL MYOPATHIES: EP. 51 Treatment of an animal model carrying recessive RYR1 mutations with inhibitors targeting epigenetic enzymes A Ruiz, C Bachmann, S Benucci, M Franchini, S Treves, F Zorzato Neuromuscular Disorders 31, S64-S65, 2021 | | 2021 |
| Characterization of a novel mouse model carrying the homozygous p. F4976L RYR1 mutation, identified in a severely affected child S Benucci, M Franchini, A Ruiz, C Bachmann, L Ruggiero, L Santoro, ... NEUROMUSCULAR DISORDERS 31, S65-S65, 2021 | | 2021 |
| CONGENITAL MYOPATHIES: EP. 52 Characterization of a novel mouse model carrying the homozygous p. F4976L RYR1 mutation, identified in a severely affected child S Benucci, M Franchini, A Ruiz, C Bachmann, L Ruggiero, L Santoro, ... Neuromuscular Disorders 31, S65, 2021 | | 2021 |
